Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
12.86
-0.27 (-2.06%)
At close: Aug 24, 2026, 4:00 PM EDT
13.07
+0.21 (1.63%)
Pre-market: Aug 25, 2026, 8:02 AM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $984.03 million as of August 25, 2026. Its market cap has increased by 201.27% in one year.
Market Cap
984.03M
Enterprise Value
831.98M
1-Year Change
201.27%
Ranking
Category
Stock Price
$12.86
ChartMarket Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $984.03M, an increase of 342.48%. That is a compound annual growth rate of 34.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 984.03M | 217.25% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 1.06B |
| Kura Oncology | 1.06B |
| Wave Life Sciences | 1.04B |
| Arbutus Biopharma | 1.03B |
| Lexicon Pharmaceuticals | 1.02B |
| Solid Biosciences | 997.19M |
| Climb Bio | 992.50M |
| Immix Biopharma | 977.23M |